These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30894414)

  • 1. A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.
    Yang Y; Liu Z; He X; Yang J; Wu J; Yang H; Li M; Qian Q; Lai R; Xu W; Wei L
    J Biol Chem; 2019 May; 294(19):7615-7631. PubMed ID: 30894414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mycobacteriophage-derived trehalose-6,6'-dimycolate-binding peptide containing both antimycobacterial and anti-inflammatory abilities.
    Wei L; Wu J; Liu H; Yang H; Rong M; Li D; Zhang P; Han J; Lai R
    FASEB J; 2013 Aug; 27(8):3067-77. PubMed ID: 23603838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin.
    Khara JS; Wang Y; Ke XY; Liu S; Newton SM; Langford PR; Yang YY; Ee PL
    Biomaterials; 2014 Feb; 35(6):2032-8. PubMed ID: 24314557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles.
    Tenland E; Pochert A; Krishnan N; Umashankar Rao K; Kalsum S; Braun K; Glegola-Madejska I; Lerm M; Robertson BD; Lindén M; Godaly G
    PLoS One; 2019; 14(2):e0212858. PubMed ID: 30807612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions.
    Amaral EP; Conceição EL; Costa DL; Rocha MS; Marinho JM; Cordeiro-Santos M; D'Império-Lima MR; Barbosa T; Sher A; Andrade BB
    BMC Microbiol; 2016 Oct; 16(1):251. PubMed ID: 27793104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Mycobacterium tuberculosis clearance after the restoration of IFN-γ
    Kamboj D; Gupta P; Basil MV; Mohan A; Guleria R; Bhatnagar A; Mehta G; Kumar P; Saurabh A; Deepak R; Thakral D; Misra P; Tandon R; Gupta UD; Mitra DK
    Eur J Immunol; 2020 May; 50(5):736-747. PubMed ID: 32113187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel synergistic enzyme-antibiotic therapy with immobilization of mycobacteriophage Lysin B enzyme onto Rif@UiO-66 nanocomposite for enhanced inhaled anti-TB therapy; Nanoenzybiotics approach.
    Eldin ZE; Dishisha T; Sayed OM; Salama HM; Farghali A
    Int J Biol Macromol; 2024 Mar; 262(Pt 1):129675. PubMed ID: 38280693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity.
    Shin A; Lee E; Jeon D; Park YG; Bang JK; Park YS; Shin SY; Kim Y
    Biochemistry; 2015 Jun; 54(25):3921-31. PubMed ID: 26053120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.
    Sahiratmadja E; Alisjahbana B; de Boer T; Adnan I; Maya A; Danusantoso H; Nelwan RH; Marzuki S; van der Meer JW; van Crevel R; van de Vosse E; Ottenhoff TH
    Infect Immun; 2007 Feb; 75(2):820-9. PubMed ID: 17145950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-mycobacterial peptides: from human to phage.
    Teng T; Liu J; Wei H
    Cell Physiol Biochem; 2015; 35(2):452-66. PubMed ID: 25613372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment.
    Silva JP; Gonçalves C; Costa C; Sousa J; Silva-Gomes R; Castro AG; Pedrosa J; Appelberg R; Gama FM
    J Control Release; 2016 Aug; 235():112-124. PubMed ID: 27261333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic modifications of the immunomodulating peptide thymopentin to confer anti-mycobacterial activity.
    Wang Y; Ke XY; Khara JS; Bahety P; Liu S; Seow SV; Yang YY; Ee PL
    Biomaterials; 2014 Mar; 35(9):3102-9. PubMed ID: 24411680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human xenobiotic nuclear receptor contributes to nonresponsiveness of
    Bhagyaraj E; Tiwari D; Ahuja N; Nanduri R; Saini A; Kalra R; Kumar S; Janmeja AK; Gupta P
    J Biol Chem; 2018 Mar; 293(10):3747-3757. PubMed ID: 29358328
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumour necrosis factor-alpha in patients with fresh active tuberculosis but not in MDR tuberculosis.
    Sharma S; Sharma M; Roy S; Kumar P; Bose M
    Immunol Cell Biol; 2004 Aug; 82(4):377-82. PubMed ID: 15283847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis.
    Semple PL; Binder AB; Davids M; Maredza A; van Zyl-Smit RN; Dheda K
    Am J Respir Crit Care Med; 2013 Jun; 187(11):1249-58. PubMed ID: 23590266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-708-5p regulates mycobacterial vitality and the secretion of inflammatory factors in Mycobacterium tuberculosis-infected macrophages by targeting TLR4.
    Li WT; Zhang Q
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8028-8038. PubMed ID: 31599428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing α-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: Discerning the role of hydrophobicity and helicity.
    Khara JS; Lim FK; Wang Y; Ke XY; Voo ZX; Yang YY; Lakshminarayanan R; Ee PLR
    Acta Biomater; 2015 Dec; 28():99-108. PubMed ID: 26380930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacteriophage D29 Lysin B exhibits promising anti-mycobacterial activity against drug-resistant
    Singh AK; Gangakhedkar R; Thakur HS; Raman SK; Patil SA; Jain V
    Microbiol Spectr; 2023 Dec; 11(6):e0459722. PubMed ID: 37800970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against
    Chen Y; Xiao JN; Li Y; Xiao YJ; Xiong YQ; Liu Y; Wang SJ; Ji P; Zhao GP; Shen H; Lu SH; Fan XY; Wang Y
    Front Immunol; 2018; 9():3190. PubMed ID: 30700988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.